Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Press Releases
Sort By
Newest First
1 / 153
1 / 153
Cell Therapy
Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA
Genezen
July 02, 2024
PR-07-24-NI-01
Monoclonal Antibodies
Coriolis Pharma Launches U.S. Entity Alongside Innovative Drug Product Platform Service Offerings for Monoclonal Antibodies
Coriolis Pharma
June 18, 2024
PR-05-24-NI-02
Sterile Fill-Finish
PCI Pharma Services Begins Installation of Sterile Fill-Finish and Lyophilization Line as Part of $100 Million New Facility Expansion
PCI Pharma Services
May 02, 2024
PR-M05-24-01
FDA Approval
Possible New Hope for Metastatic Cancer Patients: Food and Drug Administration Grants Approval for Clinical Trials For Lamassu's Groundbreaking Cancer Treatment Protocol
Lamassu Biotech
April 19, 2024
PR-M04-24-01
ESG
Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report
PCI Pharma Services
March 27, 2024
PR-M03-24-04
Lead Share Agreement
List Biotherapeutics and Sacco System Announce Lead Share Agreement
List Bio
March 14, 2024
PR-M03-24-03
Biomanufacturing
Antheia and Olon Continue Partnership for Biomanufacturing Antheia’s Pipeline of KSMs and APIs for Essential Medicines
Antheia
March 13, 2024
PR-M03-24-02
Manufacturing Partnership
Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement with Seattle Children’s Research Institute for X-linked Agammaglobulinemia (XLA) Cell Therapy Program
Genezen
March 06, 2024
PR-M03-24-01-5831
Clinical Trial Enrollment
NMDP Announces Enrollment of First Patient in OPTIMIZE Clinical Trial
NMDP
March 05, 2024
PR-M03-24-01
Portable CMC
Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human Use
Wheeler Bio
February 29, 2024
PR-M02-29-01
Lentivirus Production
Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System
Genezen
February 21, 2024
PR-M02-05-02
High Potency API Suite
Expanding Capabilities for Clients:Olon to Open New High Potency API Suite in US
Olon
February 05, 2024
PR-M02-24-01
CDMO Rebranding
Suanfarma Unifies Its Industrial Brands in a Rebranding Initiative Under Suanfarma CDMO
Suanfarma CDMO
January 31, 2024
PR-M01-24-03
Appointment
SGD Pharma Announces the Appointment of Fabio Invernizzi, General Manager West Business Unit
SGD Pharma
January 17, 2024
PR-M01-24-02
CDMO
Vetter becomes a member of the German Association of Research-Based Pharmaceutical Companies (vfa)
Vetter
January 17, 2024
PR-M01-24-01
Vetter joins Science Based Targets Initiative
Vetter
December 05, 2023
PR-M12-23-01
Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC
Wheeler Bio
November 08, 2023
PR-M11-23-01
Strategic Partnership
Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies
Samsung Biologics
October 24, 2023
PR-M10-23-06
Digitalization, AI, and Automation
Digitalization, AI, and Automation Lead Pack of Advances Fueling Life Sciences Industry Growth, New CRB Report Finds
CRB
October 19, 2023
PR-M10-23-05
In Vitro Biology
Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
Piramal Pharma Solutions
October 17, 2023
PR-M10-23-04